heiBIB: Grüllich, Carsten

Grüllich, Carsten Dr. med.Universität HeidelbergHeidelberg

Refine publication list

Year of publication

Type of Publication

List

Language

English (55)
German (10)

Co-author (Univ. of Heidelberg)

more ...

Co-author (external)

more ...

Publications in heiBIB

Penny, Hweixian Leong: Characterization and root cause analysis of immunogenicity to pasotuxizumab (AMG 212), a prostate-specific membrane antigen-targeting bispecific T-cell engager therapy / Hweixian Leong Penny, Kelly Hainline, Nathaniel Theoharis, Bin Wu, Christian Brandl, Christian Webho… , 23 October 2023. - 23 S. : Illustrationen
In: Frontiers in immunology, ISSN 1664-3224. 14(2023) vom: Okt., Artikel-ID 1261070, Seite 1-23
DOI: 10.3389/fimmu.2023.1261070
Ihrig, Andreas: Couples coping with advanced prostate cancer : an explorative study on treatment decision making, mental deterioration, partnership, and psychological burden / Andreas Ihrig, Tobias Hanslmeier, Carsten Grüllich, Stefanie Zschäbitz, Johannes Huber, Anja Greinac… , 29 January 2022. - 9 S.
In: Urologic oncology, ISSN 1873-2496. 40(2022), 2 vom: Feb., Seite 58.e17-58.e25
DOI: 10.1016/j.urolonc.2021.07.016
Hummel, Horst-Dieter: Pasotuxizumab, a BiTE® immune therapy for castration-resistant prostate cancer : phase I, dose-escalation study findings / Horst-Dieter Hummel, Peter Kufer, Carsten Grüllich, Ruth Seggewiss-Bernhardt, Barbara Deschler-Baier… , February 2021. - 17 S.
In: Immunotherapy, ISSN 1750-7448. 13(2021), 2 vom: Nov., Seite 125-141
DOI: 10.2217/imt-2020-0256
Ihrig, Andreas: Patient expectations are better for immunotherapy than traditional chemotherapy for cancer / Andreas Ihrig, Jenniffer Richter, Carsten Grüllich, Leonidas Apostolidis, Peter Horak, Matthias Vill… , 19 August 2020. - 10 S.
In: Journal of cancer research and clinical oncology, ISSN 1432-1335. 146(2020), 12, Seite 3189-3198
DOI: 10.1007/s00432-020-03336-1
Nientiedt, Cathleen: High prevalence of DNA damage repair gene defects and TP53 alterations in men with treatment-naïve metastatic prostate cancer : Results from a prospective pilot study using a 37 gene panel / Cathleen Nientiedt, Volker Endris, Maximilian Jenzer, Josef Mansour, Nassim Tawanaie Pour Sedehi, Ca… , 10 April 2020. - 11 S.
In: Urologic oncology, ISSN 1873-2496. 38(2020), 7, Seite 637.e17-637.e27
DOI: 10.1016/j.urolonc.2020.03.001
Alwers, Elizabeth: O-018 - microsatellite instability and survival after adjuvant chemotherapy among stage II and III colon cancer patients : results from a population-based study / A. Elizabeth, L. Jansen, B. Hendrik, M. Kloor, K. Tagscherer, W. Roth, D. Boakye, E. Herpel, C. Grül… , 2019. - 1 S.
In: Annals of oncology, ISSN 1569-8041. 30(2019), Suppl. 4, Seite iv132
DOI: 10.1093/annonc/mdz154.017
Seitz, Anna Katharina: Molekulares Tumorboard Prostatakarzinom / A.K. Seitz, M.M. Heck, M.W. Kamer, C. Grüllich, 2. Mai 2019. - 8 S.
In: Der Urologe. 58(2019), 7, Seite 752-759
DOI: 10.1007/s00120-019-0933-2
Apostolidis, Leonidas: Clinical characteristics, treatment outcomes and potential novel therapeutic options for patients with neuroendocrine carcinoma of the prostate / Leonidas Apostolidis, Cathleen Nientiedt, Eva Caroline Winkler, Anne Katrin Berger, Clemens Kratochw… , January 01, 2019. - 13 S.
In: OncoTarget, ISSN 1949-2553. 10(2018), 1, Seite 17-29
DOI: 10.18632/oncotarget.26523
Donskov, Frede: Outcomes based on age in the phase III METEOR trial of cabozantinib versus everolimus in patients with advanced renal cell carcinoma / Frede Donskov, Robert J. Motzer, Eric Voog, Elizabeth Hovey, Carsten Grüllich, Louise M. Nott, Katha… , 2020. - 10 S.
In: European journal of cancer, ISSN 1879-0852. 126(2020), Seite 1-10
DOI: 10.1016/j.ejca.2019.10.032
Jenzer, Maximilian: The BRCA2 mutation status shapes the immune phenotype of prostate cancer / Maximilian Jenzer, Peter Keß, Cathleen Nientiedt, Volker Endris, Maximilian Kippenberger, Jonas Leic… , 23 September 2019. - 13 S.
In: Cancer immunology immunotherapy, ISSN 1432-0851. 68(2019), 10, Seite 1621-1633
DOI: 10.1007/s00262-019-02393-x
Grüllich, Carsten: Viel Neues in Diagnostik und Therapie des Nierenzellkarzinoms / Carsten Grüllich, Klaus Höffken, 14 May 2019. - 2 S.
In: Der Onkologe, ISSN 1433-0415. 25(2019), 6, Seite 480-481
DOI: 10.1007/s00761-019-0585-2
Grüllich, Carsten: Nierenzellkarzinom / Carsten Grüllich, 08 May 2019. - 1 S.
In: Der Onkologe, ISSN 1433-0415. 25(2019), 6, Seite 482-482
DOI: 10.1007/s00761-019-0570-9
Rexer, Heidrun: Erst- und Zweitlinientherapie beim metastasierten kastrationsrefraktären Prostatakarzinom (mCRPC) : eine Phase-II-Studie zu Nivolumab in Kombination mit Rucaparib, Docetaxel oder Enzalutamid bei Männern mit kastrationsresistentem metastasiertem Prostatakarzinom (CheckMate-9KD) – AP 103/18 der AUO / H. Rexer, P. Hammerer, C. Grüllich, 2019. - 2 S.
In: Der Urologe. 58(2019), 4, Seite 475-476
DOI: 10.1007/s00120-019-0909-2
Buck, Emanuel: Tumor response to irinotecan is associated with CYP3A5 expression in colorectal cancer / Emanuel Buck, Martin Sprick, Matthias M. Gaida, Carsten Grüllich, Tim Frederik Weber, Esther Herpel,… , [April 2019]. - 9 S. : Illustrationen
In: Oncology letters, ISSN 1792-1082. 17(2019), 4, Seite 3890-3898
DOI: 10.3892/ol.2019.10043
Zschäbitz, Stefanie: Lenvantinib : a tyrosine kinase inhibitor of VEGFR 1-3, FGFR 1-4, PDGFRα, KIT and RET / Stefanie Zschäbitz, Carsten Grüllich, 02 August 2018. - 12 S.
In: Small molecules in oncology. (2018), Seite 187-198
DOI: 10.1007/978-3-319-91442-8_13
Zschäbitz, Stefanie: Survival outcomes of patients with germ cell tumors treated with high-dose chemotherapy for refractory or relapsing disease / Stefanie Zschäbitz, Florian A. Distler, Benjamin Krieger, Patrick Wuchter, Kerstin Schäfer-Eckart, M… , April 27, 2018. - 9 S.
In: OncoTarget, ISSN 1949-2553. 9(2018), 32, Seite 22537-22545
DOI: 10.18632/oncotarget.25162
Dieffenbacher, Svenja: Prospective single center trial of next-generation sequencing analysis in metastatic renal cell cancer : the MORE-TRIAL / Svenja Dieffenbacher, Stefanie Zschäbitz, Luisa Hofer, Gencay Hatiboglu, Weibin Hou, Markus Hohenfel… , 14 Mar 2018. - 6 S.
In: Future Science OA, ISSN 2056-5623. 4(2018,5) Artikel-Nummer FSO299, 6 Seiten
DOI: 10.4155/fsoa-2017-0150
Pecqueux, Carine: FGF-2 is a driving force for chromosomal instability and a stromal factor associated with adverse clinico-pathological features in prostate cancer / Carine Pecqueux, Aysenur Arslan, Martina Heller, Michael Falkenstein, Adam Kaczorowski, Yanis Tolsto… , [2018]. - 12 S. : Illustrationen
In: Urologic oncology, ISSN 1873-2496. 36(2018), 8, Seite 365.e15-365.e26
DOI: 10.1016/j.urolonc.2018.05.020
Kesch, Claudia: Correlation between genomic index lesions and mpMRI and 68 Ga-PSMA-PET/CT imaging features in primary prostate cancer / Claudia Kesch, Jan-Philipp Radtke, Axel Wintsche, Manuel Wiesenfarth, Mariska Luttje, Claudia Gasch,… , 12 November 2018. - 8 S.
In: Scientific reports, ISSN 2045-2322. 8(2018) Artikel-Nummer 16708, 8 Seiten
DOI: 10.1038/s41598-018-35058-3
Toberer, Ferdinand: Testicular choriocarcinoma with cutaneous metastasis in a 19-year-old man / Ferdinand Toberer, Alexander Enk, Wolfgang Hartschuh, Carsten Grüllich, 17 April 2018. - 4 S.
In: Journal of cutaneous pathology, ISSN 1600-0560. 45(2018), 7, Seite 535-538
DOI: 10.1111/cup.13261
Warsow, Gregor: Genomic features of renal cell carcinoma with venous tumor thrombus / Gregor Warsow, Daniel Hübschmann, Kortine Kleinheinz, Cathleen Nientiedt, Martina Heller, Laura Van … , 10 May 2018. - 12 S.
In: Scientific reports, ISSN 2045-2322. 8(2018) Artikel-Nummer 7477, 12 Seiten
DOI: 10.1038/s41598-018-25544-z
Berger, Anne Katrin: Early metabolic response in sequential FDG-PET/CT under cetuximab is a predictive marker for clinical response in first-line metastatic colorectal cancer patients : results of the phase II REMOTUX trial / Anne Katrin Berger, Stephan Lücke, Ulrich Abel, Georg Martin Haag, Carsten Grüllich, Annika Stange, … , 2018. - 6 S.
In: British journal of cancer, ISSN 1532-1827. 119(2018), 2, Seite 170-175
DOI: 10.1038/s41416-018-0152-4
Chen, Xin: Overexpression of nuclear AR-V7 protein in primary prostate cancer is an independent negative prognostic marker in men with high-risk disease receiving adjuvant therapy / Xin Chen, Christof Bernemann, Yuri Tolkach, Martina Heller, Cathleen Nientiedt, Michael Falkenstein,… , 2018. - 12 S.
In: Urologic oncology, ISSN 1873-2496. 36(2018), 4, Seite 161.e19-161.e30
DOI: 10.1016/j.urolonc.2017.11.001
Zschäbitz, Stefanie: Efficacy of cabazitaxel treatment in metastatic castration resistant prostate cancer in second and later lines : an experience from two german centers / Stefanie Zschäbitz, Sonia Vallet, Boris Hadaschik, Daniel Debatin, Stefan Fuxius, Andreas Karcher, S… , 2017.02.11. - 6 S.
In: Journal of cancer, ISSN 1837-9664. 8(2017), 4, Seite 507-512
DOI: 10.7150/jca.17644
Dietz, Steffen: Patient-specific molecular alterations are associated with metastatic clear cell renal cell cancer progressing under tyrosine kinase inhibitor therapy / Steffen Dietz, Holger Sültmann, YueJun Du, Eva Reisinger, Anja Lisa Riediger, Anna-Lena Volckmar, Al… , May 23, 2017. - 9 S.
In: OncoTarget, ISSN 1949-2553. 8(2017), 43, Seite 74049-74057
DOI: 10.18632/oncotarget.18200
Ihrig, Andreas: Results of a patient survey for assessment services in renal transplant patients with a history of cancer / Andreas Ihrig, Imad Maatouk, Susanne Fink, Sascha Pahernik, Caner Süsal, Johannes Huber, Markus Hohe… , September 28, 2017. - 4 S.
In: Progress in transplantation, ISSN 2164-6708. 27(2017), 4, Seite 365-368
DOI: 10.1177/1526924817731884
Nientiedt, Cathleen: Mutations in BRCA2 and taxane resistance in prostate cancer / Cathleen Nientiedt, Martina Heller, Volker Endris, Anna-Lena Volckmar, Stefanie Zschäbitz, María A. … , 4 July 2017. - 10 S.
In: Scientific reports, ISSN 2045-2322. 7(2017), Artikel-ID 4574
DOI: 10.1038/s41598-017-04897-x
Menzer, Christian: Editorial on the use of immunotherapy in renal-cell carcinoma : promising results in combination therapy with ipilimumab and nivolumab / Christian Menzer, Carsten Gruellich, Jessica C. Hassel, Sep 11, 2017. - 4 S.
In: Translational cancer research, ISSN 2219-6803. 6(2017), Supplement 7, Seite S1208-S1211
DOI: 10.21037/tcr.2017.09.23
Hatiboglu, Gencay: Effective downsizing but enhanced intratumoral heterogeneity following neoadjuvant sorafenib in patients with non-metastatic renal cell carcinoma / Gencay Hatiboglu, Markus Hohenfellner, Aysenur Arslan, Boris Hadaschik, Dogu Teber, Jan Philipp Radt… , 2017. - 8 S.
In: Langenbeck's archives of surgery, ISSN 1435-2451. 402(2017), 4, Seite 637-644
DOI: 10.1007/s00423-016-1543-8
Goebell, Peter Jürgen: The PAZOREAL noninterventional study to assess effectiveness and safety of pazopanib and everolimus in the changing metastatic renal cell carcinoma treatment landscape / Peter J Goebell, Christian Doehn, Carsten Grüllich, Viktor Grünwald, Thomas Steiner, Rainer Ehneß & … . - 9 S.
In: Future oncology, ISSN 1744-8301. 13(2017), 17, S. 1463-1471
DOI: 10.2217/fon-2017-0083
Zschäbitz, Stefanie: Response to anti-programmed cell death protein-1 antibodies in men treated for platinum refractory germ cell cancer relapsed after high-dose chemotherapy and stem cell transplantation / Stefanie Zschäbitz, Felix Lasitschka, Boris Hadaschik, Ralf-Dieter Hofheinz, Kathleen Jentsch-Ullric… , 4 March 2017. - 7 S.
In: European journal of cancer, ISSN 1879-0852. 76(2017), Seite 1-7
DOI: 10.1016/j.ejca.2017.01.033
Grüllich, Carsten: Immuntherapien als moderne Tumortherapien / C. Grüllich. - 4 S.
In: Der Radiologe, ISSN 1432-2102. 57(2017), 10, S. 822-825
DOI: 10.1007/s00117-017-0298-8
Hofer, Luisa: Level-IV-Cavathrombus : eine seltene Diagnose bei Patienten mit Nierenzellkarzinom / L. Hofer, C. Gasch, G. Hatiboglu, J. Motsch, C. Grüllich, S. Duensing, M. Hohenfellner. - 8 S.
In: Der Urologe. 56(2017), 7, S. 868-875
DOI: 10.1007/s00120-017-0369-5
Rosenberger, Friederike: Resistance training as supportive measure in advanced cancer patients undergoing TKI therapy : a controlled feasibility trial / F. Rosenberger, J. Wiskemann, S. Vallet, G. M. Haag, E. Schembri, D. Jäger, C. Grüllich, December 2017. - 10 S.
In: Supportive care in cancer, ISSN 1433-7339. 25(2017), 12, Seite 3655-3664
DOI: 10.1007/s00520-017-3788-3
Kordes, Maximilian: Cooperation of BRAF F595L and mutant HRAS in histiocytic sarcoma provides new insights into oncogenic BRAF signaling / M. Kordes, M. Röring, C. Heining, S. Braun, B. Hutter, D. Richter, C. Geörg, C. Scholl, S. Gröschel,… , 2016. - 10 S.
In: Leukemia, ISSN 1476-5551. 30(2016), 4, Seite 937-946
DOI: 10.1038/leu.2015.319
Höfflin, Rouven: Spatial niche formation but not malignant progression is a driving force for intratumoural heterogeneity / Rouven Hoefflin, Bernd Lahrmann, Gregor Warsow, Daniel Hübschmann, Cathleen Spath, Britta Walter, Xi… , 13 Jun 2016. - 12 S.
In: Nature Communications, ISSN 2041-1723. 7(2016) Artikel-Nummer ncomms11845, 12 Seiten
DOI: 10.1038/ncomms11845
Du, YueJun: Local recurrence after curative surgical treatment of renal cell cancer : a study of 91 patients / YueJun Du, Carsten Grüllich, Boris Hadaschik, Gencay Hatiboglu, Markus Hohenfellner, Sascha Pahernik, August 2016. - 7 S.
In: Clinical genitourinary cancer, ISSN 1938-0682. 14(2016), 4, Seite e379-e385
DOI: 10.1016/j.clgc.2016.01.012
Macher-Göppinger, Stephan: MET expression and copy number status in clear-cell renal cell carcinoma : prognostic value and potential predictive marker / Stephan Macher-Goeppinger, Martina Keith, Volker Endris, Roland Penzel, Katrin E. Tagscherer, Sascha… , 2017. - 12 S.
In: OncoTarget, ISSN 1949-2553. 8(2017), 1, Seite 1046-1057
DOI: 10.18632/oncotarget.13540
Nientiedt, Cathleen: PARP inhibition in BRCA2-mutated prostate cancer / C. Nientiedt, Y. Tolstov, A.-L. Volckmar, V. Endris, D. Bonekamp, U. Haberkorn, D. Jäger, H. Sültman… , 2017. - 3 S.
In: Annals of oncology, ISSN 1569-8041. 28(2017), 1, Seite 189-191
DOI: 10.1093/annonc/mdw445
Zschäbitz, Stefanie: Activity of immune checkpoint inhibition in platinum refractory germ-cell tumors / S. Zschäbitz, F. Lasitschka, D. Jäger and C. Grüllich, 30 March 2016. - 5 S.
In: Annals of oncology, ISSN 1569-8041. 27(2016), 7, Seite 1356-1360
DOI: 10.1093/annonc/mdw146
Du, YueJun: Impact of resection and systemic therapy on the survival of patients with brain metastasis of metastatic renal cell carcinoma / YueJun Du, Sascha Pahernik, Boris Hadaschik, Dogu Teber, Stephan Duensing, Dirk Jäger, Markus Hohenf… , 18 August 2016. - 8 S.
In: Journal of neuro-oncology, ISSN 1573-7373. 130(2016), 1, Seite 221-228
DOI: 10.1007/s11060-016-2238-2
Du, YueJun: Survival and prognostic factors of patients with renal cell cancer with bone metastasis in the era of targeted therapy : A single-institution analysis / YueJun Du, Sascha Pahernik, Boris Hadaschik, Dogu Teber, Stephan Duensing, Dirk Jäger, Markus Hohenf… , 16 May 2016. - 8 S.
In: Urologic oncology, ISSN 1873-2496. 34(2016), 10, Seite 433.e1-433.e8
DOI: 10.1016/j.urolonc.2016.05.017
Grüllich, Carsten: Erste randomisierte Phase-3-Studie zur adjuvanten Therapie mit einem Tyrosinkinaseinhibitor bei Hochrisiko-Nierenzellkarzinom / Carsten Grüllich. - 3 S.
In: Der Onkologe, ISSN 1433-0415. 22(2016), 11, S. 886-888
DOI: 10.1007/s00761-016-0096-3
Ziegler, Christian Martin: Features of cell death, mitochondrial activation and caspase dependence of rabbit anti-T-lymphocyte globulin signaling in lymphoblastic Jurkat cells are distinct from classical apoptosis signaling of CD95 / Christian Ziegler, Jürgen Finke, Carsten Grüllich, 2016. - 5 S.
In: Leukemia and lymphoma, ISSN 1029-2403. 57(2016), 1, Seite 177-182
DOI: 10.3109/10428194.2015.1044449
Grüllich, Carsten: Local salvage therapy for late (≥2 years) metastatic and local relapse of renal cell cancer is a potentially curative treatment irrespective of the site of recurrence / Carsten Grüllich, M.D., Sonia Vallet, M.D., Christopher Hecht, Stephan Duensing, M.D., Ph.D., Boris … , 2016. - 9 S.
In: Urologic oncology, ISSN 1873-2496. 34(2016), 5, Seite 238.e9-238.e17
DOI: 10.1016/j.urolonc.2015.11.022
Höfner, Thomas: Docetaxel followed by abiraterone in metastatic castration-resistant prostate cancer : efficacy and predictive parameters in a large single center cohort / Thomas Höfner, Sonia Vallet, Boris A. Hadaschik, Sascha Pahernik, Stefan Duensing, Markus Hohenfelln… , 2015. - 7 S.
In: World journal of urology, ISSN 1433-8726. 33(2015), 6, Seite 833-839
DOI: 10.1007/s00345-014-1375-5
Höfflin, Rouven: Intratumorale Heterogenität des Nierenzellkarzinoms : Molekulare Grundlagen und translationale Implikationen / R. Höfflin, W. Roth, H. Sültmann, C. Grüllich, G. Hatiboglu, J. Nyarangi-Dix, G. Schönberg, D. Teber… , June 2015. - 4 S.
In: Der Urologe. 54(2015), 6, Seite 800-803
DOI: 10.1007/s00120-015-3800-9
Mang, Josef: Prognostic significance and functional role of CEP57 in prostate cancer / Josef Mang, Nina Korzeniewski, Dimo Dietrich, Verena Sailer, Yanis Tolstov, Sam Searcy, Jost von Har… , December 2015. - 10 S.
In: Translational oncology, ISSN 1936-5233. 8(2015), 6, Seite 487-496
DOI: 10.1016/j.tranon.2015.11.004
Zhou, Xiaoguang: Uncoupling of PUMA expression and apoptosis contributes to functional heterogeneity in renal cell carcinoma : prognostic and translational implications / Xiaoguang Zhou, Jielin Li, Christina Marx, Yanis Tolstov, Geraldine Rauch, Esther Herpel, Stephan Ma… , 12 December 2015. - 7 S.
In: Translational oncology, ISSN 1936-5233. 8(2015), 6, Seite 480-486
DOI: 10.1016/j.tranon.2015.11.003
Huber, Johannes: Interdisciplinary counseling service for renal malignancies : a patient-centered approach to raise guideline adherence / Johannes Huber, M.D., Ph.D., Andreas Ihrig, Ph.D., Eva Winkler, M.D., Ph.D., Anette Brechtel, Ph.D.,… , 2015. - 7 S.
In: Urologic oncology, ISSN 1873-2496. 33(2015), 1, Seite 23.e1-23.e7
DOI: 10.1016/j.urolonc.2014.10.017
Ziegler, Christian Martin: Rabbit anti-T-lymphocyte globulin (ATG) persists with differential reactivity in patients' sera after full hematopoetic regeneration from allogeneic stem cell transplantation / Christian Ziegler, Jürgen Finke, Carsten Grüllich, 13 April 2014. - 4 S.
In: Transplant immunology, ISSN 1878-5492. 30(2014), 4, Seite 136-139
DOI: 10.1016/j.trim.2014.03.005
Schneider, Meike: The tyrosine kinase inhibitor nilotinib has antineoplastic activity in prostate cancer cells but up-regulates the ERK survival signal : implications for targeted therapies / Meike Schneider, M.D., Nina Korzeniewski, Ph. D., Konstanze Merkle, Julia Schüler, D.V.M., Ph. D., C… , 2015. - 7 S.
In: Urologic oncology, ISSN 1873-2496. 33(2015), 2, Seite 72.e1-72.e7
DOI: 10.1016/j.urolonc.2014.06.001
Grüllich, Carsten: Cabozantinib : a MET, RET, and VEGFR2 tyrosine kinase inhibitor / Carsten Grüllich, 23 April 2014. - 8 S.
In: Small molecules in oncology. (2014), Seite 207-214
Vallet, Sonia: Efficacy of targeted treatment beyond third-line therapy in metastatic kidney cancer : retrospective analysis from a large-volume cancer center / Sonia Vallet, Sascha Pahernik, Thomas Höfner, Georgi Tosev, Boris Hadaschik, Stefan Duensing, Oliver… , 2015. - 8 S.
In: Clinical genitourinary cancer, ISSN 1938-0682. 13(2015), 3, Seite e145-e152
DOI: 10.1016/j.clgc.2014.12.012
Schneider, Meike: Phenotypic drug screening and target validation for improved personalized therapy reveal the complexity of phenotype-genotype correlations in clear cell renal cell carcinoma / Meike Schneider, Julia Schüler, Rouven Höfflin, Nina Korzeniewski, Carsten Grüllich, Wilfried Roth, … , August 2014. - 8 S.
In: Urologic oncology, ISSN 1873-2496. 32(2014), 6, Seite 877-884
DOI: 10.1016/j.urolonc.2014.03.011
Zhou, Xiaoguang: Harnessing the p53-PUMA axis to overcome DNA damage resistance in renal cell carcinoma / Xiaoguang Zhou, Yanis Tolstov, Aysenur Arslan, Wilfried Roth, Carsten Grüllich, Sascha Pahernik, Mar… . - 8 S.
In: Neoplasia, ISSN 1476-5586. 16(2014), 12, S. 1028-1035
DOI: 10.1016/j.neo.2014.09.012
Röder, Falk: Excellent local control with IOERT and postoperative EBRT in high grade extremity sarcoma : results from a subgroup analysis of a prospective trial / Falk Roeder, Burkhard Lehner, Thomas Schmitt, Bernd Kasper, Gerlinde Egerer, Oliver Sedlaczek, Carst… , 2014. - 12 S.
In: BMC cancer, ISSN 1471-2407. 14(2014) Artikel-Nr. 350, 12 S.
DOI: 10.1186/1471-2407-14-350
Georgi, Björn: Evolving therapeutic concepts in prostate cancer based on genome-wide analyses (Review) / Björn Georgi ; Nina Korzeniewski ; Boris Hadaschik ; Carsten Grüllich ; Wilfried Roth ; Holger Sültm… . - 8 S.
In: International journal of oncology, ISSN 1791-2423. 45(2014), 4, S. 1337-1344
DOI: 10.3892/ijo.2014.2567
Sedlaczek, Oliver: Organtoxizität medikamentöser Tumortherapien : morphologische Korrelate / O. Sedlaczek, C. Grüllich, M. Röthke, H.-P. Schlemmer, H.-U. Kauczor, 29. März 2013. - 7 S.
In: Der Radiologe, ISSN 1432-2102. 53(2013), 4, Seite 329-335
DOI: 10.1007/s00117-012-2428-7
Fritsch, Kristina: Suppression of granzyme B activity and caspase-3 activation in leukaemia cells constitutively expressing the protease inhibitor 9 / Kristina Fritsch, Jürgen Finke, Carsten Grüllich, 28 July 2013. - 7 S.
In: Annals of hematology, ISSN 1432-0584. 92(2013), 12, Seite 1603-1609
DOI: 10.1007/s00277-013-1846-6
Förster, Robert: Posterior reversible leukoencephalopathy syndrome associated with pazopanib / Robert Förster, Thomas Welzel, Jürgen Debus, Carsten Grüllich, Dirk Jäger, Karin Potthoff, April 6, 2013. - 5 S.
In: Case reports in oncology, ISSN 1662-6575. 6(2013), 1, Seite 204-208
DOI: 10.1159/000350742
Hadaschik, Boris: Die Urologie im Konzept der „Comprehensive Cancer Center“ / B. Hadaschik, S. Pahernik, C. Grüllich, H. Sültmann, D. Jäger, C. von Kalle, S. Duensing, M. Hohenfe… , 15. August 2013. - 7 S.
In: Der Urologe. 52(2013), 9, Seite 1283-1289
DOI: 10.1007/s00120-013-3313-3
Schröttner, Percy: Achievement of a continuous complete remission in a kidney transplant patient with advanced donor-derived small cell carcinoma / Percy Schroettner, Carsten Gruellich, Jens Hasskarl, Cornelius F. Waller, July 15, 2010. - 2 S.
In: Transplantation, ISSN 1534-6080. 90(2010), 1, Seite 94-95
DOI: 10.1097/TP.0b013e3181d9e1ac

IDs

GND:

14101914X

Links

Grüllich, Carsten in ...

Export publication list

heiBIB

Please contact biblio@ub.uni-heidelberg.de in case of any errors or omissions.

Information concerning heiBIB (including embedding the publication list in existing websites).

Impressum / Datenschutz Design